Reference
Newman DB, et al. Cost Efficacy of alpha-Galactosidase A Enzyme Screening for Fabry Disease. Mayo Clinic Proceedings 94: 84-88, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.mayocp.2018.08.009
Rights and permissions
About this article
Cite this article
Enzyme screening less costly than genetic testing for Fabry's disease. PharmacoEcon Outcomes News 820, 14 (2019). https://doi.org/10.1007/s40274-019-5593-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5593-3